RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
-8.99%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$798M
AUM Growth
+$798M
(-12%)
Cap. Flow
-$2.7M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
29.72%
Holding
97
New
9
Increased
24
Reduced
42
Closed
4
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$27.9M |
| 2 |
Merck
MRK
|
$18.1M |
| 3 |
AbbVie
ABBV
|
$12.9M |
| 4 |
Esperion Therapeutics
ESPR
|
$8.94M |
| 5 |
Nektar Therapeutics
NKTR
|
$8.65M |
Top Sells
| 1 |
Horizon Bancorp
HBNC
|
$26.2M |
| 2 |
Humana
HUM
|
$11.5M |
| 3 |
Incyte
INCY
|
$8.5M |
| 4 |
HCA Healthcare
HCA
|
$7.37M |
| 5 |
Elevance Health
ELV
|
$7.2M |
Sector Composition
| 1 | Healthcare | 92.7% |
| 2 | Industrials | 0.42% |
| 3 | Technology | 0.13% |
| 4 | Financials | 0.1% |
| 5 | Energy | 0.08% |
